MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Myriad Genetics ROCE Ratio 2011-2025 | MYGN
Annual ROCE Ratio Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.62 | -32.87 | -15.87 | -19.68 | -9.97 | 0.7 | 5.36 | 4.91 | 20.64 | 19.24 | 36.93 | 30.84 | 27.93 | 27.37 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.93 | -32.87 | 5.56 |
Quarterly ROCE Ratio Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -96.54 | -95.22 | -11.33 | -20.13 | -26.19 | -36.72 | -30.51 | -35.42 | -31.53 | -17.95 | -9.48 | -17.73 | -21.07 | -21.5 | -15.89 | -21.36 | -17.61 | -23.05 | -22.21 | -17.56 | -15.01 | -8.07 | -5.49 | -4.1 | -2.05 | -0.61 | 1.42 | 1.54 | 11.07 | 11.02 | 22.14 | 23.8 | 15.12 | 16.33 | 5.93 | 9.44 | 14.78 | 19.83 | 25.54 | 24.9 | 22.24 | 20.46 | 17.53 | 24.57 | 32.95 | 39.29 | 47.06 | 43.18 | 38.81 | 36.16 | 32.42 | 31.4 | 30.92 | 30.2 | 29.87 | 7.16 | 8.02 | 7.32 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.06 | -96.54 | 1.35 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 19.16 | -1.11 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 20.5 | -4.92 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.23 | -2.26 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 230.58 | 0.1 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.56 | 5.18 % | $ 300 M | Israel |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.5 | -1.07 % | $ 1.91 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.62 | 0.04 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
28.89 | $ 67.79 | 0.33 % | $ 26.2 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 26.61 | -0.41 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 19.02 | -2.36 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 101.2 | -1.03 % | $ 3.99 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-69.16 | $ 3.2 | - | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 226.58 | -0.15 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
317.65 | $ 101.62 | -1.32 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 4.81 | -5.39 % | $ 2.58 M | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 7.2 | 0.91 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
81.8 | $ 18.82 | 0.83 % | $ 462 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 133.99 | -0.71 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 203.2 | -0.17 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 175.29 | -0.38 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 6.8 | -0.29 % | $ 882 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.25 | 0.53 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 253.12 | -0.33 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 183.24 | 0.22 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 684.16 | -0.63 % | $ 56.4 B | USA |
 |
Personalis
PSNL
|
-33.64 | $ 8.02 | -1.47 % | $ 475 M | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 66.86 | 0.22 % | $ 4.63 B | USA |
 |
Quidel Corporation
QDEL
|
69.35 | $ 29.14 | -0.55 % | $ 1.23 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 415.25 | -0.36 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
25.0 | $ 138.08 | -0.22 % | $ 42 B | USA |
 |
RadNet
RDNT
|
11.59 | $ 73.09 | -0.08 % | $ 5.34 B | USA |